Related Experiment Video
Updated: May 26, 2026
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Practical considerations of percutaneous ventricular assist devices
1Section of Cardiology, University of Chicago Medical Center, Chicago, Illinois, USA.
The Journal of Invasive Cardiology
|January 3, 2012
Summary
Percutaneous ventricular assist devices offer vital short-term support for failing left ventricles, enabling high-risk procedures outside the operating room. Evidence confirms their efficacy and safety for critical cardiovascular care.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Devices
Background:
- Percutaneous ventricular assist devices (PVADs) are expanding the use of left ventricular support beyond the operating room.
- These devices facilitate high-risk procedures and support failing left ventricles until native recovery.
- PVADs are increasingly utilized in interventional suites and cardiovascular care units.
Purpose of the Study:
- To review the growing body of evidence on the efficacy and safety of PVADs.
- To highlight the clinical importance and applications of PVADs.
- To provide technical considerations and troubleshooting insights for healthcare providers.
Main Methods:
- Review of existing literature on percutaneous ventricular assist devices.
- Analysis of clinical data regarding device efficacy and safety.
- Compilation of technical aspects and troubleshooting strategies.
Main Results:
- Evidence demonstrates the efficacy and safety of PVADs for left ventricular support.
- PVADs enable high-risk procedures and support native heart recovery.
- Growing body of evidence supports their clinical importance.
Conclusions:
- Percutaneous ventricular assist devices are crucial for short-term left ventricular support.
- These devices are effective and safe, expanding treatment options in cardiovascular care.
- Further insights into technical considerations are valuable for providers.
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:25Hemodialysis I: Introduction
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.